In a lung model of pulmonary inflammation known as idiopathic pneumonia syndrome (IPS), an HDAC inhibitor induced L-kynurenine and suppressed IL-17 and IL-6 expression, and these damage-related responses were reversed after treatment with the AhR antagonist CH223191 [80]. Here, IL6 is linked to ichthyosis prematurity syndrome.